Brighton Jones LLC Acquires 1,260 Shares of Intuitive Surgical, Inc. $ISRG

Brighton Jones LLC raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 33.3% during the second quarter, Holdings Channel reports. The institutional investor owned 5,047 shares of the medical equipment provider’s stock after buying an additional 1,260 shares during the quarter. Brighton Jones LLC’s holdings in Intuitive Surgical were worth $2,742,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in the business. Vanguard Group Inc. lifted its stake in shares of Intuitive Surgical by 1.4% in the first quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock valued at $16,178,258,000 after buying an additional 453,335 shares in the last quarter. Invesco Ltd. lifted its stake in shares of Intuitive Surgical by 1.7% in the first quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock valued at $2,090,027,000 after buying an additional 71,794 shares in the last quarter. Northern Trust Corp lifted its stake in shares of Intuitive Surgical by 0.3% in the first quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock valued at $1,798,465,000 after buying an additional 11,988 shares in the last quarter. Wellington Management Group LLP lifted its stake in shares of Intuitive Surgical by 15.0% in the first quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock valued at $1,732,975,000 after buying an additional 457,080 shares in the last quarter. Finally, Nuveen LLC bought a new position in shares of Intuitive Surgical in the first quarter valued at $1,715,899,000. 83.64% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research firms have weighed in on ISRG. The Goldman Sachs Group dropped their price objective on shares of Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating on the stock in a research note on Wednesday, October 1st. Deutsche Bank Aktiengesellschaft reiterated a “sell” rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Piper Sandler increased their target price on shares of Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. Mizuho set a $575.00 target price on shares of Intuitive Surgical in a report on Wednesday. Finally, Sanford C. Bernstein reiterated an “outperform” rating and issued a $685.00 target price on shares of Intuitive Surgical in a report on Tuesday, October 21st. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $602.32.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $546.51 on Monday. The firm has a market cap of $195.91 billion, a price-to-earnings ratio of 72.29, a P/E/G ratio of 5.02 and a beta of 1.61. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The firm’s 50-day simple moving average is $458.09 and its two-hundred day simple moving average is $497.11.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. The business had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company’s revenue for the quarter was up 22.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.84 earnings per share. Analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Activity

In other news, Director Amy L. Ladd sold 335 shares of Intuitive Surgical stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $440.69, for a total value of $147,631.15. Following the completion of the transaction, the director owned 739 shares in the company, valued at $325,669.91. This trade represents a 31.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the transaction, the insider owned 19,827 shares of the company’s stock, valued at $9,368,059.23. The trade was a 59.69% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 30,031 shares of company stock worth $14,177,895. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.